Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Angiology ; 49(2): 157-60, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9482516

ABSTRACT

Pyoderma gangrenosum is a rare cutaneous disorder frequently associated with systemic diseases. The authors report the case of a 28-year-old man with pyoderma gangrenosum and inferior cava vein syndrome due to thrombosis. The search for pyoderma gangrenosum-associated conditions (gastrointestinal, rheumatic, neoplasic, and infectious diseases) was negative. A prolonged partial thromboplastin time and a positive test for circulating anticardiolipin antibodies strongly suggested the diagnosis of the antiphospholipid syndrome. There are reports of at least three other cases of pyoderma gangrenosum associated with the antiphospholipid syndrome. This clinical case adds further evidence to the possible link between these disorders and warrants a search for anticardiolipin antibodies in patients with pyoderma gangrenosum.


Subject(s)
Antiphospholipid Syndrome/complications , Iliac Vein , Pyoderma Gangrenosum/complications , Thrombosis/complications , Vena Cava, Inferior , Adult , Antibodies, Antiphospholipid/analysis , Antiphospholipid Syndrome/diagnosis , Antiphospholipid Syndrome/immunology , Humans , Male , Phlebography , Pyoderma Gangrenosum/diagnosis , Thrombosis/diagnosis , Thrombosis/surgery
2.
Gac Med Mex ; 128(3): 253-7, 1992.
Article in Spanish | MEDLINE | ID: mdl-1302725

ABSTRACT

94 patients with renal allograft from a living related donor were studied in three different groups: 1 Patients with identical histocompatibility (n-32), treated with prednisone (PDN) and azathioprine (Aza); 2 Haploidentical patients (34) who received PDN, Aza and cyclosporine (CsA); 3 Haploidentical patients (28) who previous to the transplantation received specific donor blood transfusions and Aza/PDN after the transplantation. The survival for the patient and the graft after five years was 100% and 96% in group 1; 97% y 89% in group 2 and 82% and 72% in group 3. Five patients in group 1 received CsA also. There was no mortality in group 1, while there were one death in group 2 and two more in group 3. There was no significant difference between CsA and Blood transfusions in the patients and grafts survival.


Subject(s)
Blood Transfusion , Immunosuppression Therapy/methods , Kidney Transplantation/immunology , Adolescent , Adult , Azathioprine/administration & dosage , Blood Transfusion/statistics & numerical data , Confidence Intervals , Cyclosporine/administration & dosage , Female , Graft Survival , Humans , Immunosuppression Therapy/statistics & numerical data , Kidney Transplantation/mortality , Kidney Transplantation/statistics & numerical data , Male , Odds Ratio , Prednisone/administration & dosage , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL